Ovid Therapeutics OVID
NASDAQ OVID
$2.80 +0.02 (+0.72%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ovid Therapeutics (OVID) Net Equity Issued and Repurchased (2019 - 2026)

Ovid Therapeutics' (OVID) quarterly Net Equity Issued and Repurchased came in at $1000.0 in Q2 2026, down 99.96% quarter-over-quarter from $2.4 million in Q1 2026.

Analysis

Ovid Therapeutics (OVID) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends

Ovid Therapeutics (OVID) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $1000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $1000.0; the trailing twelve-month figure through Jun 2026 stood at $2.4 million (up 11005.38% YoY), and the FY2020 full-year result was $46.7 million, down 27.12% from the prior year.
  • Net Equity Issued and Repurchased fell to $1000.0 in Q2 2026 per OVID's latest filing, from $2.4 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $2.4 million in Q1 2026 and bottomed at $1000.0 in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn -
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - 141.90 Mn
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn -
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
10 Ovid Therapeutics 517.32 Mn 400.10 Mn - 1,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Mar 31, 2026 2.37 Mn
Dec 31, 2021 21,314.00
Mar 31, 2021 -21,314.00
Dec 31, 2020 -221,065.00
Jun 30, 2020 8,368.00
Mar 31, 2020 -67,575.00
Dec 31, 2019 33.60 Mn
Jun 30, 2019 -391,885.00
Mar 31, 2019 30.91 Mn